Ozempic counterfeit scam: Delhi Police issue Lookout Circular against alleged mastermind Swapnadip Roy

The investigation into the Rs 157 crore international counterfeit Ozempic scam, which sent shockwaves through the global pharmaceutical community, has escalated with a primary focus now shifting toward Dubai-based Indian national Swapnadip Roy.
Sources confirm that the Economic Offences Wing (EOW) of the Delhi Police has officially issued a Lookout Circular (LOC) against Roy.
This move aims to prevent his movement across international borders and ensure his apprehension, as he is currently believed to be hiding in Dubai. The hunt for Roy intensified after Vicky Ramancha, CEO of R&R Global Procurement Corp., and the initial central figure in the probe, disclosed Roy’s name during the investigation.
Ramancha alleged that Roy, an Indian passport holder from Tripura, was the “key architect” who orchestrated the entire transnational scam. Despite multiple notices sent to his Tripura address and a formal summons under the Bharatiya Nagarik Suraksha Sanhita (BNSS), Roy has remained elusive.
The EOW has now categorised him as a key accused, seeking to unearth a conspiracy that spans India, Dubai, China, and the USA.
The case began when US-based Assure Global LLC alleged that they were duped out of approximately $18.8 million (approximately Rs 157 crore). The firm had entered into a deal for 1.25 lakh doses of Ozempic, a high-demand anti-diabetic and weight-loss drug. Instead of genuine medication, the company allegedly received “spurious” or misbranded drugs shipped from China, which were subsequently seized by US authorities. The fraud was allegedly given a veneer of legitimacy through the use of forged documents, including fake government credentials and notarised papers from the Patiala House Courts.
Funds were allegedly routed through Ramancha’s Dubai-based entity, M/s RNR Premier Medical Equipments Trading LLC.
In September 2025, the Delhi Police filed a status report before the Delhi High Court, noting Roy’s involvement and his failure to cooperate. While the High Court had previously granted Ramancha interim protection from arrest-contingent on his cooperation-the police have highlighted that crucial financial trails, including bank statements from Dubai and proof of payment to Chinese suppliers, remain undisclosed.
The High Court is closely monitoring the progress, viewing the scam not merely as a commercial dispute-as the defence claims-but as a “sophisticated transnational fraud” and a threat to public health.
The EOW is expected to apprise the high court on the next date of hearing on July 14, 2026, of the specific steps taken to extradite or apprehend Roy, whose custodial interrogation is now seen as the “litmus test” for dismantling this global counterfeit network.
Lawyers for Assure Global have expressed hope that custodial interrogation of the key players will eventually expose the entire syndicate involved in this high-stakes conspiracy.















